Trinity Biotech | TRIB - Debt


Trinity Biotech reported $100.76M in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Bayer EUR 39.39B 1.31B Mar/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
EDAP TMS EUR 8.96M 4.96M Jun/2025
J&J USD 45.8B 4.97B Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Siemens EUR 56.69B 834M Jun/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Tosoh JPY 172.31B 6.79B Sep/2025
Trinity Biotech USD 100.76M 7.05M Dec/2024
Veracyte USD 50.65M 145K Jun/2025